Corrigendum: Phase I trial outcome of amnion cell therapy in patients with ischemic stroke (I-ACT) (Frontiers in Neuroscience, (2023), 17, (1153231), 10.3389/fnins.2023.1153231)

Thanh G. Phan; Rebecca Lim; Mirja Krause; Siow T. Chan; Hannah McDonald; Poh Yi Gan; Shenpeng R. Zhang; Liz J. Barreto Arce; Jason Vuong; Tharani Thirugnanachandran; Benjamin Clissold; John Ly; Shaloo Singhal; Marie Veronic Hervet; Hyun Ah Kim; Grant R. Drummond; Euan M. Wallace; Henry Ma; Christopher G. Sobey

doi:10.3389/fnins.2023.1237920

Corrigendum: Phase I trial outcome of amnion cell therapy in patients with ischemic stroke (I-ACT) (Frontiers in Neuroscience, (2023), 17, (1153231), 10.3389/fnins.2023.1153231)

Thanh G. Phan, Rebecca Lim, Mirja Krause, Siow T. Chan, Hannah McDonald, Poh Yi Gan, Shenpeng R. Zhang, Liz J. Barreto Arce, Jason Vuong, Tharani Thirugnanachandran, Benjamin Clissold, John Ly, Shaloo Singhal, Marie Veronic Hervet, Hyun Ah Kim, Grant R. Drummond, Euan M. Wallace, Henry Ma, Christopher G. Sobey

Research output: Contribution to journal › Comment / Debate › Other › peer-review

Abstract

In the published article, there was an error in the author list, and author “Mirja Krause” was erroneously excluded. The corrected author list and author contributions section are appears below. “Thanh G. Phan^{1, 2*}, Rebecca Lim^{3, 4}, Mirja Krause^{3, 4}, Siow T. Chan^{3, 4}, Hannah McDonald^{3, 4}, Poh-Yi Gan^{5, 6}, Shenpeng R. Zhang⁷, Liz J. Barreto Arce⁷, Jason Vuong^{1, 2}, Tharani Thirugnanachandran^{1, 2}, Benjamin Clissold^{1, 2}, John Ly^{1, 2}, Shaloo Singhal^{1, 2}, Marie Veronic Hervet^{1, 2}, Hyun Ah Kim⁷, Grant R. Drummond⁷, Euan M. Wallace^{4, 8}, Henry Ma^{1, 2} and Christopher G. Sobey⁷^*” TP, HMa, RL, EW, and CS designed the trial protocol and were major contributors in the writing of the manuscript. JV performed image analysis. TT, BC, JL, and SS recruited patients and performed clinical assessments. RL, MK, SC, and HMc prepared cells for administration to patients. MH administered cell infusions and collected the patient data. P-YG, SZ, LB, and HK performed the analyses of blood samples for inflammatory markers. CS and GD analyzed the data. All authors contributed to the article and approved the submitted version. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Original language	English
Article number	1237920
Number of pages	1
Journal	Frontiers in Neuroscience
Volume	17
DOIs	https://doi.org/10.3389/fnins.2023.1237920
Publication status	Published - 2023

Keywords

allogeneic
clinical trial
ischemic stroke
phase I
stem cell

Access to Document

10.3389/fnins.2023.1237920Licence: CC BY

Cite this

Phan, T. G., Lim, R., Krause, M., Chan, S. T., McDonald, H., Gan, P. Y., Zhang, S. R., Barreto Arce, L. J., Vuong, J., Thirugnanachandran, T., Clissold, B., Ly, J., Singhal, S., Hervet, M. V., Kim, H. A., Drummond, G. R., Wallace, E. M., Ma, H., & Sobey, C. G. (2023). Corrigendum: Phase I trial outcome of amnion cell therapy in patients with ischemic stroke (I-ACT) (Frontiers in Neuroscience, (2023), 17, (1153231), 10.3389/fnins.2023.1153231). Frontiers in Neuroscience, 17, Article 1237920. https://doi.org/10.3389/fnins.2023.1237920

@article{1dc1555e30024ac2a47e344b70584f12,

title = "Corrigendum: Phase I trial outcome of amnion cell therapy in patients with ischemic stroke (I-ACT) (Frontiers in Neuroscience, (2023), 17, (1153231), 10.3389/fnins.2023.1153231)",

abstract = "In the published article, there was an error in the author list, and author “Mirja Krause” was erroneously excluded. The corrected author list and author contributions section are appears below. “Thanh G. Phan1, 2*, Rebecca Lim3, 4, Mirja Krause3, 4, Siow T. Chan3, 4, Hannah McDonald3, 4, Poh-Yi Gan5, 6, Shenpeng R. Zhang7, Liz J. Barreto Arce7, Jason Vuong1, 2, Tharani Thirugnanachandran1, 2, Benjamin Clissold1, 2, John Ly1, 2, Shaloo Singhal1, 2, Marie Veronic Hervet1, 2, Hyun Ah Kim7, Grant R. Drummond7, Euan M. Wallace4, 8, Henry Ma1, 2 and Christopher G. Sobey7*” TP, HMa, RL, EW, and CS designed the trial protocol and were major contributors in the writing of the manuscript. JV performed image analysis. TT, BC, JL, and SS recruited patients and performed clinical assessments. RL, MK, SC, and HMc prepared cells for administration to patients. MH administered cell infusions and collected the patient data. P-YG, SZ, LB, and HK performed the analyses of blood samples for inflammatory markers. CS and GD analyzed the data. All authors contributed to the article and approved the submitted version. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.",

keywords = "allogeneic, clinical trial, ischemic stroke, phase I, stem cell",

author = "Phan, {Thanh G.} and Rebecca Lim and Mirja Krause and Chan, {Siow T.} and Hannah McDonald and Gan, {Poh Yi} and Zhang, {Shenpeng R.} and {Barreto Arce}, {Liz J.} and Jason Vuong and Tharani Thirugnanachandran and Benjamin Clissold and John Ly and Shaloo Singhal and Hervet, {Marie Veronic} and Kim, {Hyun Ah} and Drummond, {Grant R.} and Wallace, {Euan M.} and Henry Ma and Sobey, {Christopher G.}",

note = "Publisher Copyright: Copyright {\textcopyright} 2023 Phan, Lim, Krause, Chan, McDonald, Gan, Zhang, Barreto Arce, Vuong, Thirugnanachandran, Clissold, Ly, Singhal, Hervet, Kim, Drummond, Wallace, Ma and Sobey.",

year = "2023",

doi = "10.3389/fnins.2023.1237920",

language = "English",

volume = "17",

journal = "Frontiers in Neuroscience",

issn = "1662-4548",

publisher = "Frontiers Media SA",

}

Phan, TG , Lim, R, Krause, M, Chan, ST, McDonald, H, Gan, PY, Zhang, SR, Barreto Arce, LJ, Vuong, J, Thirugnanachandran, T, Clissold, B, Ly, J, Singhal, S, Hervet, MV, Kim, HA, Drummond, GR, Wallace, EM , Ma, H & Sobey, CG 2023, 'Corrigendum: Phase I trial outcome of amnion cell therapy in patients with ischemic stroke (I-ACT) (Frontiers in Neuroscience, (2023), 17, (1153231), 10.3389/fnins.2023.1153231)', Frontiers in Neuroscience, vol. 17, 1237920. https://doi.org/10.3389/fnins.2023.1237920

Corrigendum: Phase I trial outcome of amnion cell therapy in patients with ischemic stroke (I-ACT) (Frontiers in Neuroscience, (2023), 17, (1153231), 10.3389/fnins.2023.1153231). / Phan, Thanh G.; Lim, Rebecca; Krause, Mirja et al.
In: Frontiers in Neuroscience, Vol. 17, 1237920, 2023.

Research output: Contribution to journal › Comment / Debate › Other › peer-review

TY - JOUR

T1 - Corrigendum

T2 - Phase I trial outcome of amnion cell therapy in patients with ischemic stroke (I-ACT) (Frontiers in Neuroscience, (2023), 17, (1153231), 10.3389/fnins.2023.1153231)

AU - Phan, Thanh G.

AU - Lim, Rebecca

AU - Krause, Mirja

AU - Chan, Siow T.

AU - McDonald, Hannah

AU - Gan, Poh Yi

AU - Zhang, Shenpeng R.

AU - Barreto Arce, Liz J.

AU - Vuong, Jason

AU - Thirugnanachandran, Tharani

AU - Clissold, Benjamin

AU - Ly, John

AU - Singhal, Shaloo

AU - Hervet, Marie Veronic

AU - Kim, Hyun Ah

AU - Drummond, Grant R.

AU - Wallace, Euan M.

AU - Ma, Henry

AU - Sobey, Christopher G.

PY - 2023

Y1 - 2023

N2 - In the published article, there was an error in the author list, and author “Mirja Krause” was erroneously excluded. The corrected author list and author contributions section are appears below. “Thanh G. Phan1, 2*, Rebecca Lim3, 4, Mirja Krause3, 4, Siow T. Chan3, 4, Hannah McDonald3, 4, Poh-Yi Gan5, 6, Shenpeng R. Zhang7, Liz J. Barreto Arce7, Jason Vuong1, 2, Tharani Thirugnanachandran1, 2, Benjamin Clissold1, 2, John Ly1, 2, Shaloo Singhal1, 2, Marie Veronic Hervet1, 2, Hyun Ah Kim7, Grant R. Drummond7, Euan M. Wallace4, 8, Henry Ma1, 2 and Christopher G. Sobey7*” TP, HMa, RL, EW, and CS designed the trial protocol and were major contributors in the writing of the manuscript. JV performed image analysis. TT, BC, JL, and SS recruited patients and performed clinical assessments. RL, MK, SC, and HMc prepared cells for administration to patients. MH administered cell infusions and collected the patient data. P-YG, SZ, LB, and HK performed the analyses of blood samples for inflammatory markers. CS and GD analyzed the data. All authors contributed to the article and approved the submitted version. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

AB - In the published article, there was an error in the author list, and author “Mirja Krause” was erroneously excluded. The corrected author list and author contributions section are appears below. “Thanh G. Phan1, 2*, Rebecca Lim3, 4, Mirja Krause3, 4, Siow T. Chan3, 4, Hannah McDonald3, 4, Poh-Yi Gan5, 6, Shenpeng R. Zhang7, Liz J. Barreto Arce7, Jason Vuong1, 2, Tharani Thirugnanachandran1, 2, Benjamin Clissold1, 2, John Ly1, 2, Shaloo Singhal1, 2, Marie Veronic Hervet1, 2, Hyun Ah Kim7, Grant R. Drummond7, Euan M. Wallace4, 8, Henry Ma1, 2 and Christopher G. Sobey7*” TP, HMa, RL, EW, and CS designed the trial protocol and were major contributors in the writing of the manuscript. JV performed image analysis. TT, BC, JL, and SS recruited patients and performed clinical assessments. RL, MK, SC, and HMc prepared cells for administration to patients. MH administered cell infusions and collected the patient data. P-YG, SZ, LB, and HK performed the analyses of blood samples for inflammatory markers. CS and GD analyzed the data. All authors contributed to the article and approved the submitted version. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

KW - allogeneic

KW - clinical trial

KW - ischemic stroke

KW - phase I

KW - stem cell

UR - http://www.scopus.com/inward/record.url?scp=85168107507&partnerID=8YFLogxK

U2 - 10.3389/fnins.2023.1237920

DO - 10.3389/fnins.2023.1237920

M3 - Comment / Debate

AN - SCOPUS:85168107507

SN - 1662-4548

VL - 17

JO - Frontiers in Neuroscience

JF - Frontiers in Neuroscience

M1 - 1237920

ER -

Corrigendum: Phase I trial outcome of amnion cell therapy in patients with ischemic stroke (I-ACT) (Frontiers in Neuroscience, (2023), 17, (1153231), 10.3389/fnins.2023.1153231)

Abstract

Keywords

Access to Document

Other files and links

Research output

Phase I trial outcome of amnion cell therapy in patients with ischemic stroke (I-ACT)

Cite this